FPT drives innovation in Healthcare & Life Science with AI at DeviceTalks Boston 2026

FPT continues to affirm its position on the U.S. technology map by serving as a Gold Sponsor at DeviceTalks Boston 2026, bringing forward advanced AI-powered solutions to enhance the efficiency of medical devices, diagnostics, and connected wearables. The event not only created opportunities to engage with industry leaders but also reinforced FPT’s commitment to advancing digital transformation in Healthcare & Life Science with a patient-centric approach.

Recognized as a premier gathering for experts who are actively shaping the future of patient care, DeviceTalks Boston features in-depth discussions on product design, manufacturing, company building, fundraising, and emerging healthcare technologies.

As part of the event, FPT hosted a Lunch & Learn session titled “Transforming Medical Devices, Diagnostics, and Wearables with AI.” The session focused on how AI is accelerating innovation and creating real value across the entire healthcare technology ecosystem—from enhancing the performance of medical devices and diagnostic capabilities to enabling smarter, more connected wearable solutions.

In addition to highlighting the growing role of AI in healthcare, FPT representatives also engaged attendees in discussions about the opportunities and challenges organizations face as they accelerate digital transformation. These activities opened up valuable networking opportunities with healthcare leaders, technology innovators, and industry partners, further strengthening FPT’s presence in the rapidly growing Healthcare & Life Science ecosystem.

FPT’s participation at DeviceTalks Boston 2026 reflects its ongoing commitment to supporting healthcare organizations in harnessing the power of AI and emerging technologies to drive meaningful impact. As healthcare innovation continues to evolve, FPT remains dedicated to collaborating with industry leaders to build smarter, more connected, and more patient-centric solutions.